Back to search

A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis

Data up to Jan 2025

Published2000
Citations93
References36

Total Citations Per Year

Abstract

References (36)

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Nonparametric Estimation from Incomplete Observations

1958 • 37,219 citations

Nonparametric Statistics for the Behavioral Sciences

1958 • 36,277 citations

The Positive and Negative Syndrome Scale (PANSS) for Schizophrenia

1987 • 19,723 citations

Diagnostic and Statistical Manual of Mental Disorders

1988 • 12,705 citations

ECDEU Assessment Manual for Psychopharmacology

1976 • 8,729 citations

Nonparametric Statistics for the Behavioral Sciences.

1957 • 8,423 citations

Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset.

1998 • 1,795 citations

Goodman and Gilman's The Pharmacological Basis of Therapeutics

1991 • 1,330 citations

Risperidone in the treatment of schizophrenia

1994 • 1,205 citations

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1996 • 1,143 citations

A Canadian Multicenter Placebo-Controlled Study of Fixed Doses of Risperidone and Haloperidol in the Treatment of Chronic Schizophrenic Patients

1993 • 884 citations

Psychopharmacology: The Fourth Generation of Progress

1995 • 842 citations

Comparison of Risperidone and Placebo for Psychosis and Behavioral Disturbances Associated With Dementia

1999 • 726 citations

Risperidone in the Treatment of Patients with Chronic Schizophrenia: a Multi-National, Multi-Centre, Double-Blind, Parallel-Group Study versus Haloperidol

1995 • 558 citations

Pyramidical Model of Schizophrenia

1990 • 434 citations

Does risperidone improve verbal working memory in treatment-resistant schizophrenia?

1997 • 406 citations

Severity of symptoms in chronically institutionalized geriatric schizophrenic patients

1995 • 307 citations

Risk of Tardive Dyskinesia in Older Patients

1995 • 302 citations

Lower Incidence of Tardive Dyskinesia with Risperidone Compared with Haloperidol in Older Patients

1999 • 231 citations

Principles of Therapeutics

1992 • 187 citations

Positive and negative syndromes in schizophrenia: Assessment and research.

1991 • 185 citations

Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs

1996 • 172 citations

Positive and negative syndromes in schizophrenia: Assessment and research

1992 • 150 citations

Efficacy of risperidone treatment for psychoses associated with schizophrenia, schizoaffective disorder, bipolar disorder, or senile dementia in 11 geriatric patients: a case series.

1995 • 111 citations

Risperidone versus haloperidol for perception of emotion in treatment-resistant schizophrenia: preliminary findings

1998 • 106 citations

The Effect of Risperidone on Cognition in Patients with Schizophrenia

1996 • 63 citations

Burned-out Schizophrenia: Evidence for Age Effects on Schizophrenic Symptomatology

1978 • 59 citations

Risperidone in the Treatment of Elderly Patients With Psychotic Disorders

1999 • 54 citations

A Two‐Year Follow‐Up of Geriatric Consults in the Emergency Department

1998 • 44 citations

Management of Depression in the Elderly

1989 • 35 citations

Risperidone in Elderly Schizophrenic Patients: An Open-Label Trial

1996 • 30 citations

Antipsychotic drug use in older adults

1994 • 27 citations

Outcome of Risperidone Therapy in Elderly Patients with Chronic Psychosis

1996 • 24 citations

Newer antipsychotics and antidepressants for elderly people

1996 • 19 citations

Management of the Behavioral Symptoms Associated with Dementia

1989 • 11 citations

Cited By (0)

Loading...
A long-term, multicenter, open-label study of risperidone in elderly patients with… (2000) – International Journal of Geriatric Psychiatry | Metascience Observatory Explorer